Jade Biosciences Inc. (JBIO)
NASDAQ · Healthcare
Jade Biosciences Inc. Revenue 2025–2025
Jade Biosciences Inc. annual/quarterly revenue history and growth rate from 2025 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Jade Biosciences Inc. revenue for the quarter ending March 31, 2026 was 0.
- Jade Biosciences Inc. revenue for the twelve months ending March 31, 2026 was 0.
- Jade Biosciences Inc. annual revenue for 2025 was 0.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Jade Biosciences Inc. (JBIO) — Frequently Asked Questions
Jade Biosciences Inc. (JBIO) is a publicly traded US company. It has a market capitalization of $495M. Explore JBIO's stock price, financial statements, earnings history, margins and key ratios below.
What is Jade Biosciences Inc.'s market cap?
Jade Biosciences Inc. (JBIO) has a market capitalization of $495M.
What is the JBIO stock price?
JBIO trades at $15.79 (+3.51% on the day).
Is JBIO profitable?
In fiscal 2025, Jade Biosciences Inc. reported net income of -$127M.